Antisense Therapeutics Ltd (ANP.AX)

ANP.AX on Australia Stock Exchange

0.11AUD
1 Oct 2014
Price Change (% chg)

$-0.00 (-4.35%)
Prev Close
$0.12
Open
$0.12
Day's High
$0.12
Day's Low
$0.11
Volume
226,500
Avg. Vol
310,945
52-wk High
$0.23
52-wk Low
$0.10

ANP.AX

Chart for ANP.AX

About

Antisense Therapeutics Limited is an Australia-based company engaged in the research and development of novel antisense pharmaceuticals. The Company operates in two segments: Multiple Sclerosis and Growth and Sight Disorders. The Company's product development product pipeline includes ATL1101 for prostate cancer, ATL1102 for... (more)
No analyst recommendations are available for ANP.AX.

Overall

Beta: 0.01
Market Cap (Mil.): $16.57
Shares Outstanding (Mil.): 144.10
Dividend: --
Yield (%): --

Financials

  ANP.AX Industry Sector
P/E (TTM): -- 129.49 34.07
EPS (TTM): -0.02 -- --
ROI: -89.49 -1.76 17.40
ROE: -89.49 -6.56 18.25
Search Stocks

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks